{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:26:49Z","timestamp":1791588409722,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":1186,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009431","name":"Baxalta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1111\/jth.14313","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T23:49:01Z","timestamp":1540511341000},"page":"52-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery"],"prefix":"10.1016","volume":"17","author":[{"given":"F.","family":"Peyvandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mamaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010D.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Stasyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Timofeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Cid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.T.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kavakli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Castaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sytkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14313_bb0010","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"von Willebrand's disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14313_bb0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14313_bb0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-2006-949668","article-title":"Comparative analysis and classification of von Willebrand factor\/factor VIII concentrates: impact on treatment of patients with von Willebrand disease","volume":"32","author":"Budde","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14313_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5482\/HAMO-14-12-0077","article-title":"The function of ultra\u2010large von Willebrand factor multimers in high shear flow controlled by ADAMTS13","volume":"35","author":"Reininger","year":"2015","journal-title":"Hamostaseologie"},{"key":"10.1111\/jth.14313_bb0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s002770050184","article-title":"von Willebrand factor: molecular size and functional activity","volume":"72","author":"Furlan","year":"1996","journal-title":"Ann Hematol"},{"key":"10.1111\/jth.14313_bb0035","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3324\/haematol.2012.077263","article-title":"Principles of care for the diagnosis and treatment of von Willebrand disease","volume":"98","author":"Castaman","year":"2013","journal-title":"Haematologica"},{"key":"10.1111\/jth.14313_bb0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/ejh.12809","article-title":"von Willebrand disease \u2010 the \u2018Dos\u2019 and \u2018Don'ts\u2019 in surgery","volume":"98","author":"Miesbach","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.14313_bb0045","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1111\/hae.12498","article-title":"Thromboembolic incidence with transiently elevated levels of coagulation factors in patients with von Willebrand disease treated with VWF:FVIII concentrate during surgery","volume":"20","author":"Gill","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14313_bb0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/hae.13165","article-title":"Laboratory monitoring of replacement therapy for major surgery in von Willebrand disease","volume":"23","author":"Mannucci","year":"2017","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14313_bb0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MBC.0b013e3283254570","article-title":"von Willebrand factor\/factor VIII concentrates in the treatment of von Willebrand disease","volume":"20","author":"Batlle","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl 1","key":"10.1111\/jth.14313_bb0060","first-page":"S32","article-title":"Development of a plasma\u2010 and albumin\u2010free recombinant von Willebrand factor","volume":"29","author":"Turecek","year":"2009","journal-title":"Hamostaseologie"},{"key":"10.1111\/jth.14313_bb0065","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/17474086.2016.1214070","article-title":"von Willebrand factor (Vonvendi(R)): the first recombinant product licensed for the treatment of von Willebrand disease","volume":"9","author":"Franchini","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1111\/jth.14313_bb0070","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.14313_bb0075","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma\u2010free method: a prospective clinical trial","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14313_bb0080","unstructured":"European Medicines Agency. Guideline on the clinical investigation of human plasma derived von Willebrand factor products (CPMP\/BPWG\/220\/02). Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/01\/WC500067126.pdf. Last accessed May 2018."},{"key":"10.1111\/jth.14313_bb0085","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1538-7836.2007.02562.x","article-title":"Treatment of severe von Willebrand disease with a high\u2010purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients","volume":"5","author":"Borel\u2010Derlon","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14313_bb0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1358\/dot.2016.52.12.2570978","article-title":"Recombinant von Willebrand factor: a first\u2010of\u2010its\u2010kind product for von Willebrand disease","volume":"52","author":"Singal","year":"2016","journal-title":"Drugs Today (Barc)"},{"key":"10.1111\/jth.14313_bb0095","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00000542-200309000-00009","article-title":"Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty","volume":"99","author":"Mantilla","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1111\/jth.14313_bb0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12891-015-0470-0","article-title":"Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years","volume":"16","author":"Zhang","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1111\/jth.14313_bb0105","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1111\/j.1538-7836.2005.01621.x","article-title":"Deep\u2010vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography","volume":"3","author":"Piovella","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14313_bb0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3400\/avd.oa.12.00049","article-title":"Deep vein thrombosis in orthopedic surgery of the lower extremities","volume":"5","author":"Motohashi","year":"2012","journal-title":"Ann Vasc Dis"},{"key":"10.1111\/jth.14313_bb0115","first-page":"41","article-title":"Epidemiology of deep vein thrombosis in patients undergoing major lower extremity orthopedic surgery: a two\u2010year study from tertiary care hospital of north India","volume":"5","author":"Singh","year":"2017","journal-title":"Int J Sci Study"},{"key":"10.1111\/jth.14313_bb0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MBC.0000000000000065","article-title":"Update on von Willebrand factor multimers: focus on high\u2010molecular\u2010weight multimers and their role in hemostasis","volume":"25","author":"Stockschlaeder","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14313_bb0125","unstructured":"Guideline on the core SPC for human plasma derived von willebrand factor (CPMP\/BPWG\/278\/02). Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003423.pdf. Last accessed June 2018."}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14313","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14313","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14313","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622030203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622030203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:26:05Z","timestamp":1761535565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622030203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1538783622030203"],"URL":"https:\/\/doi.org\/10.1111\/jth.14313","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Shire International GmbH Journal of Thrombosis and Haemostasis. International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}